BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11960490)

  • 1. Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity.
    Liljebris C; Larsen SD; Ogg D; Palazuk BJ; Bleasdale JE
    J Med Chem; 2002 Apr; 45(9):1785-98. PubMed ID: 11960490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1B.
    Larsen SD; Barf T; Liljebris C; May PD; Ogg D; O'Sullivan TJ; Palazuk BJ; Schostarez HJ; Stevens FC; Bleasdale JE
    J Med Chem; 2002 Jan; 45(3):598-622. PubMed ID: 11806712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
    Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
    Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity.
    Larsen SD; Stevens FC; Lindberg TJ; Bodnar PM; O'Sullivan TJ; Schostarez HJ; Palazuk BJ; Bleasdale JE
    Bioorg Med Chem Lett; 2003 Mar; 13(5):971-5. PubMed ID: 12617932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
    Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
    Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors.
    Klopfenstein SR; Evdokimov AG; Colson AO; Fairweather NT; Neuman JJ; Maier MB; Gray JL; Gerwe GS; Stake GE; Howard BW; Farmer JA; Pokross ME; Downs TR; Kasibhatla B; Peters KG
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1574-8. PubMed ID: 16386905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
    Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
    J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
    Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
    J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.
    Jia Z; Ye Q; Dinaut AN; Wang Q; Waddleton D; Payette P; Ramachandran C; Kennedy B; Hum G; Taylor SD
    J Med Chem; 2001 Dec; 44(26):4584-94. PubMed ID: 11741477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
    Andersen HS; Olsen OH; Iversen LF; Sørensen AL; Mortensen SB; Christensen MS; Branner S; Hansen TK; Lau JF; Jeppesen L; Moran EJ; Su J; Bakir F; Judge L; Shahbaz M; Collins T; Vo T; Newman MJ; Ripka WC; Møller NP
    J Med Chem; 2002 Sep; 45(20):4443-59. PubMed ID: 12238924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B).
    Liljebris C; Martinsson J; Tedenborg L; Williams M; Barker E; Duffy JE; Nygren A; James S
    Bioorg Med Chem; 2002 Oct; 10(10):3197-212. PubMed ID: 12150865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a monoacid-based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1B.
    Xin Z; Liu G; Abad-Zapatero C; Pei Z; Szczepankiewicz BG; Li X; Zhang T; Hutchins CW; Hajduk PJ; Ballaron SJ; Stashko MA; Lubben TH; Trevillyan JM; Jirousek MR
    Bioorg Med Chem Lett; 2003 Nov; 13(22):3947-50. PubMed ID: 14592481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
    Wilson DP; Wan ZK; Xu WX; Kirincich SJ; Follows BC; Joseph-McCarthy D; Foreman K; Moretto A; Wu J; Zhu M; Binnun E; Zhang YL; Tam M; Erbe DV; Tobin J; Xu X; Leung L; Shilling A; Tam SY; Mansour TS; Lee J
    J Med Chem; 2007 Sep; 50(19):4681-98. PubMed ID: 17705360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands.
    Liu G; Xin Z; Liang H; Abad-Zapatero C; Hajduk PJ; Janowick DA; Szczepankiewicz BG; Pei Z; Hutchins CW; Ballaron SJ; Stashko MA; Lubben TH; Berg CE; Rondinone CM; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 Jul; 46(16):3437-40. PubMed ID: 12877578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular effects of small molecule PTP1B inhibitors on insulin signaling.
    Xie L; Lee SY; Andersen JN; Waters S; Shen K; Guo XL; Moller NP; Olefsky JM; Lawrence DS; Zhang ZY
    Biochemistry; 2003 Nov; 42(44):12792-804. PubMed ID: 14596593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.
    Sparks RB; Polam P; Zhu W; Crawley ML; Takvorian A; McLaughlin E; Wei M; Ala PJ; Gonneville L; Taylor N; Li Y; Wynn R; Burn TC; Liu PC; Combs AP
    Bioorg Med Chem Lett; 2007 Feb; 17(3):736-40. PubMed ID: 17097290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.
    Liu G; Szczepankiewicz BG; Pei Z; Janowick DA; Xin Z; Hajduk PJ; Abad-Zapatero C; Liang H; Hutchins CW; Fesik SW; Ballaron SJ; Stashko MA; Lubben T; Mika AK; Zinker BA; Trevillyan JM; Jirousek MR
    J Med Chem; 2003 May; 46(11):2093-103. PubMed ID: 12747781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein tyrosine phosphatase 1B inhibition: opportunities and challenges.
    Liu G
    Curr Med Chem; 2003 Aug; 10(15):1407-21. PubMed ID: 12871138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
    Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
    J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.